Xenograft Mouse Model of Human Uveal Melanoma.

Yao Chen, Xiao Liu, Ling Gao, Yongqing Liu
Author Information
  1. Yao Chen: Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha, China.
  2. Xiao Liu: Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha, China.
  3. Ling Gao: Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha, China.
  4. Yongqing Liu: Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, KY, USA.

Abstract

Uveal melanoma (UM) is a malignant intraocular tumor in adults. Metastasis develops in almost half of the patients and over 90% of the metastases are in the liver. With the advances in molecular targeting therapy for melanoma, a proper metastasis animal model is of increasing importance for testing the accuracy and effectiveness of systemic therapies. Here, we describe a xenograft model for mimicking human UM liver metastasis by injecting human UM cells into the vitreous cavity in nude mice. The athymic nude mice are immunocompromised and suitable for xenograft tumor growth and metastasis, and intravitreal injection of cells is a quicker and easier operation under a binocular scope, thereby it is simple and effective to test human UM growth and metastasis.

Keywords

References

  1. Cancer Res. 2015 Aug 15;75(16):3384-97 [PMID: 26113083]
  2. Ophthalmology. 2014 Jun;121(6):1281-8 [PMID: 24480708]
  3. Prog Retin Eye Res. 2011 Sep;30(5):285-95 [PMID: 21658465]
  4. Eye (Lond). 2013 Feb;27(2):230-42 [PMID: 23222563]
  5. Biomed Res Int. 2016;2016:4521807 [PMID: 27366747]
  6. Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):186-196 [PMID: 28399342]
  7. Cancer J. 2012 Mar-Apr;18(2):148-52 [PMID: 22453016]
  8. Br J Ophthalmol. 2005 Oct;89(10):1270-4 [PMID: 16170114]
  9. Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9 [PMID: 14578381]
  10. Melanoma Res. 2014 Dec;24(6):525-34 [PMID: 25304237]
  11. Clin Exp Ophthalmol. 2016 Aug;44(6):509-19 [PMID: 26601795]
  12. Br J Ophthalmol. 2017 Jan;101(1):38-44 [PMID: 27574175]
  13. Curr Opin Ophthalmol. 2017 May;28(3):219-227 [PMID: 28257297]
  14. Curr Eye Res. 2016;41(1):121-8 [PMID: 25658144]
  15. Curr Oncol. 2016 Feb;23(1):e57-64 [PMID: 26966414]
  16. Sci Rep. 2017 Dec;7(1):45 [PMID: 28246385]
  17. Arch Ophthalmol. 2001 May;119(5):670-6 [PMID: 11346394]
  18. Curr Oncol Rep. 2017 Jul;19(7):45 [PMID: 28508938]
  19. Oncogene. 2012 Mar 1;31(9):1105-16 [PMID: 21765463]
  20. Ophthalmology. 2011 Sep;118(9):1881-5 [PMID: 21704381]
  21. Br J Ophthalmol. 2014 Dec;98(12):1738-43 [PMID: 25147369]

Word Cloud

Created with Highcharts 10.0.0metastasisUMmelanomatumormodelhumangrowthUvealliverxenograftcellsnudemiceinjectionXenograftHumanmalignantintraocularadultsMetastasisdevelopsalmosthalfpatients90%metastasesadvancesmoleculartargetingtherapyproperanimalincreasingimportancetestingaccuracyeffectivenesssystemictherapiesdescribemimickinginjectingvitreouscavityathymicimmunocompromisedsuitableintravitrealquickereasieroperationbinocularscopetherebysimpleeffectivetestMouseModelMelanomauvealIntravitrealLiverOcularmouse

Similar Articles

Cited By